Dr. Bradley McGregor

Contributions & Related Content

Videos

Biomarkers, Frailty, and Implementing EV-Pembro in Bladder Cancer Care

Implementing KEYNOTE-905 & KEYNOTE-B15 in Community Practice

Neoadjuvant Cycles & ctDNA Decisions

KEYNOTE-B15: EV + Pembrolizumab vs GemCis in MIBC

Future Directions in RCC: Triplets, Biomarkers, and Neoadjuvant Strategies

Expanding Adjuvant Therapy in RCC

Sequencing Lenvatinib-Based Therapy in Refractory RCC

Belzutifan Combinations and Second-Line Strategy in RCC

Frontline vs Second-Line RCC Strategy: Why Getting the First Choice Right Matters

Frontline RCC Treatment: Matching the Right Regimen to the Right Patient

Podcasts

Precision Medicine in Metastatic Bladder Cancer

ctDNA in Bladder Cancer: Practice-Changing or Still Evolving?

EV Pembro and the Evolving Standard in MIBC